AV
Angelini Ventures at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Angelini Ventures takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions look at the bigger picture for the industry, from building a competitive European biotech community to biopharma alliances designed to withstand a fragmenting world. The alliances session is shared with Bayer and Evotec.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
AV Angelini Ventures Rome, Italy | |
Corporate venture capital arm of Angelini Industries, investing in biotech, medtech and digital health companies. | Keynote Mon Nov 9 12:00–12:45 Building a competitive and impactful European biotech community: Perspectives from the European Life Sciences Coalition and CEOs How Europe can keep biotech talent, money and companies at home by drawing in big investors, speeding regulation and building stronger stock markets. Ecosystem InnovationBusiness of Biotech Panel Tue Nov 10 17:00–17:45 Resilient by Design: Reinventing Biopharma Alliances in a Fragmenting World How drug companies are reshaping research and manufacturing partnerships to stay reliable as political tensions and supply chain risks divide the world. Business of BiotechBiomanufacturing Strategy |
Instantly find 20 buyers from Angelini Ventures
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction